Étienne Lavallée

Daza J, Grauer R, Chen S, Lavallèe E, Razdan S, Dey L, Steineck G, Renström-Koskela L, Li Q, Hussein AA, Mehrazin R, Waingankar N, Guru K, Wiklund P, Sfakianos JP

Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer

Urol Oncol, 2023, ISSN: 1078-1439.

Résumé | Liens:

Ghoreifi A, Mitra AP, McClintock G, Baky F, McDowell Z, Lavallée E, Saoud R, Cai J, Gill IS, Sfakianos J, Porter J, Bagrodia A, Ahmadi N, Eggener S, Ward JF, Djaladat H

Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study

Urol Oncol, 41 (2), 2023.

Résumé | Liens:

Lavallee E, Sfakianos J, Mehrazin R, Wiklund P

Detailed Description of the Karolinska Technique for Intracorporeal Studer Neobladder Reconstruction

J Endourol, 36 (S2), 2022.

Résumé | Liens:

Lavallée E, Wiklund P

The Studer Neobladder: An Established and Reproducible Technique for Intracorporeal Urinary Diversion

Eur Urol Open Sci, 35 , 2022.

| Liens:

Lavallée E, Dovey Z, Pathak P, Dey L, Renström Koskela L, Hosseini A, Waingankar N, Mehrazin R, Sfakianos J, Wiklund P

Functional and Oncological Outcomes of Female Pelvic Organ-preserving Robot-assisted Radical Cystectomy

Eur Urol Open Sci, 36 , 2022.

Résumé | Liens:

Ranti D, Pfail J, Garcia M, Razdan S, Bieber C, Rosenzweig S, Waingankar N, Hosseini A, Radros J, Mehrazin R, Lavallée E, Wiklund PN, Sfakianos JP

Neobladder creation in patients with chronic kidney disease: A viable diversion strategy

Urol Oncol, 40 (4), 2022.

Résumé | Liens:

Lavallee E, Sfakianos JP, Mulholland DJ

Tumor Heterogeneity and Consequences for Bladder Cancer Treatment

Cancers (Basel), 13 (21), 2021.

Résumé | Liens:

Otis-Chapados S, Goulet CR, Dubois G, Lavallée É, Dujardin T, Fradet Y, Lacombe L, Lodde M, Tiguert R, Toren P, Fradet V, Beauregard JM, Buteau FA, Pouliot F

18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy

Can Urol Assoc J, 15 (10), 2021.

Résumé | Liens:

Meziou S, Ringuette Goulet C, Hovington H, Lefebvre V, Lavallée É, Bergeron M, Brisson H, Champagne A, Neveu B, Lacombe D, Beauregard JM, Buteau FA, Riopel J, Pouliot F

GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome

Prostate Cancer Prostatic Dis, 23 (3), 2020.

Résumé | Liens:

Lavallée E, Bergeron M, Buteau FA, Blouin AC, Duchesnay N, Dujardin T, Tiguert R, Lacombe L, Fradet V, Makao-Nguile M, Fradet Y, Beauregard JM, Pouliot F

Increased Prostate Cancer Glucose Metabolism Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8-10 Prostate Cancers Identifies Very High-risk Patients for Early Recurrence and Resistance to Castration

Eur Urol Focus, 5 (6), 2019.

Résumé | Liens: